This is a combined synopsis/solicitation for commercial items seeking Fluorodeoxyglucose (FDG) radiopharmaceuticals. Delivery will be to the Philadelphia VA Medical Center at 3900 Woodland Avenue, Philadelphia, PA 19104. The estimated period of performance is from October 14, 2026, through October 13, 2031. The acquisition is not set aside for small business concerns. A Service Contract Act wage determination applies to this acquisition.